(Q38524618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

intermittent claudication

9 November 2019

main subject

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

A N Tenaglia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R D Anderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J B Hermiller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Rocha-Singh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F O Mendelsohn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

W R Hiatt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Moon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M J Whitehouse

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B H Annex

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

192-5, A6-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11448424%20AND%20SRC:MED&resulttype=core&format=json

Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

American Cancer Society guidelines for the early detection of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

Comparison of graded versus constant treadmill test protocols for quantifying intermittent claudication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901622-8